Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02346305
Other study ID # 2014 - NIV - 14734
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 2015
Est. completion date December 2024

Study information

Verified date March 2023
Source Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
Contact Didier FORET
Phone 33 (1) 56 81 40 60
Email antadir@antadir.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The effectiveness of NIV is clearly demonstrated but no recent studies describe the prescription based on clinical data and the conditions of using NIV at home according the various respiratory diseases. The investigators' purpose is that a better knowledge of NIV practices could improve both the quality to support patients at home and the efficacy of the treatment. The main objective of this study is to analyze the clinical data justifying the prescription of NIV advice according respiratory disease. The secondary objectives are to study comorbidities, treatment failures, survival rate during the study period.


Recruitment information / eligibility

Status Recruiting
Enrollment 3000
Est. completion date December 2024
Est. primary completion date December 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - No previous experience with domiciliary non-invasive ventilation - Adult patients, = 18 years of age - Without tracheotomy - No evolutive cancer - No significant psychiatric disease - Possible medical monitoring Exclusion Criteria: - Evolutive cancer - Inability to understand rationale and/or consent form for study

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Non-invasive ventilation
Home NIV installation

Locations

Country Name City State
France CHU d'Angers Angers
France CHU de Besançon Besançon
France CH de Cannes Cannes
France CHU de Dijon Dijon
France Garches Garches
France CHU de Grenoble Grenoble
France CHD de la Réunion La Reunion
France CHU de Lille Lille
France CHU de Limoges Limoges
France CHU de Nancy Nancy
France AP-HP Pitié-Salpêtrière Paris
France Hôpital Edouard Rist Paris
France CHU de Rouen Rouen
France CHU de Rouen Rouen
France CHU de Strasbourg Strasbourg
France CHU de Toulouse Toulouse
France Hôpital Robert Schuman Vantoux

Sponsors (1)

Lead Sponsor Collaborator
Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical data leading to NIV device prescription Age, blood gases, BMI, etiology, pulmonary function,comorbidities Day 1
Secondary Change in blood gases 4 months, 1 year and 2 years after inclusion
Secondary Change in the possible comorbidities 4 months, 1 year and 2 years after inclusion
Secondary Treatment compliance Initiation of treatment to 4 months
Secondary Treatment compliance 4 months to 1 year
Secondary Treatment compliance 1 year to 2 years (end of study)
Secondary Hospitalizations During the study period all hospitalizations will be notify 4 months
Secondary Hospitalizations During the study period all hospitalizations will be notify 1 year
Secondary Hospitalizations During the study period all hospitalizations will be notify 2 years
Secondary Survival rate 4 months
Secondary Survival rate 1 year
Secondary Survival rate 2 years
See also
  Status Clinical Trial Phase
Recruiting NCT05904652 - High Flow Nasal Oxygen at Extubation for Adults Requiring a Breathing Tube for Treating Severe Breathing Difficulties N/A
Completed NCT04030208 - Evaluating Safety and Efficacy of Umbulizer in Patients Requiring Intermittent Positive Pressure Ventilation N/A
Recruiting NCT03697785 - Weaning Algorithm for Mechanical VEntilation N/A
Recruiting NCT02989051 - Fluid Restriction Keeps Children Dry Phase 2/Phase 3
Completed NCT02930525 - Effect of High Flow Nasal Cannula vs. Standard Care on Respiratory Stability in Pediatric Procedural Sedation N/A
Recruiting NCT02539732 - Prediction of Outcome of Weaning From Mechanical Ventilation Using the Electrical Activity of the Diaphragm
Enrolling by invitation NCT02290236 - Monitored Saturation Post-ICU N/A
Completed NCT02056119 - RCT of Mesh Versus Jet Nebulizers on Clinical Outcomes During Mechanical Ventilation in the Intensive Care Unit N/A
Terminated NCT01583088 - Early Stage Amyotrophic Lateral Sclerosis Phrenic Stimulation Phase 3
Withdrawn NCT00990119 - High Flow Therapy (HFT) to Treat Respiratory Insufficiency in Chronic Obstructive Pulmonary Disease (COPD) N/A
Completed NCT00741949 - Broncho-alveolar Lavage Under Noninvasive Ventilation With Propofol TCI in Patient With AHRF Phase 3
Completed NCT01411722 - Electrical Activity of the Diaphragm During the Weaning Period Phase 2
Recruiting NCT00339053 - Immunonutrition and Thoracoabdominal Aorta Aneurysm Repair Phase 4
Recruiting NCT00187434 - Comparison of Two Methods of Continuous Positive Airway Pressure (CPAP) to Support Successful Extubation of Infants of Birth Weights ≤ 1500 Grams (C2CPAP) N/A
Completed NCT02687802 - Respiratory Mechanics and Patient-ventilator Asynchrony Index in Patients With Invasive Mechanical Ventilation
Not yet recruiting NCT05906030 - Diaphragm Dysfunction and Ultrasound Perioperatively
Completed NCT03850977 - Is There an Association Between Chronic Pancreatitis and Pulmonary Function
Completed NCT02845375 - Effect of Neuromuscular Blockade and Reversal on Breathing Phase 4
Recruiting NCT03309423 - Is Venous to Arterial Conversion (v-TAC) of Blood Gas Reliable in Critical Ill Patients in the ICU? N/A
Completed NCT04115969 - Outcome After Non-invasive Ventilation.